Withdrawal of life-support in paediatric intensive care--a study of time intervals between discussion, decision and

Felix Oberender1, James Tibballs

  • 1Intensive Care Unit, Royal Children's Hospital, Melbourne, Victoria, VIC 3052, Australia. felix.oberender@rch.org.au

BMC Pediatrics
|May 24, 2011
PubMed

Insights

The time to withdraw life-sustaining treatment and death varies greatly. Understanding these timeframes can improve end-of-life care and organ donation processes.

Area of Science:

  • Pediatric critical care medicine
  • End-of-life care research
  • Thanatology

Background:

  • Limited data exists on the temporal aspects of withdrawing life-sustaining treatment.
  • This study addresses the time course of end-of-life decisions, treatment withdrawal, and death in a pediatric intensive care unit (PICU).

Purpose of the Study:

  • To investigate the time intervals involved in the process of withdrawing life-sustaining treatment in a pediatric intensive care setting.
  • To provide data that can inform clinical practice, parental guidance, and organ procurement strategies.

Main Methods:

  • Prospective, observational study design.
  • Conducted in the intensive care unit (ICU) of a tertiary children's hospital.
  • Data collected over a 12-month period on 38 cases of withdrawal of life-sustaining treatment.

Main Results:

  • Significant variability in time from initial discussion to decision-making (median 67.8 hours).
  • Variability also observed from decision to treatment commencement (median 4.7 hours).
  • Time to death after withdrawal varied (median 10 minutes), with 21% dying over 1 hour later.

Conclusions:

  • Wide case-by-case variations exist at each stage of withdrawing life-sustaining treatment.
  • Findings can aid medical management, leadership, parental support, and organ procurement planning.
  • This knowledge is crucial for optimizing end-of-life care pathways in pediatric ICUs.
Abstract

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.